HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text All Versions of this Article: 2243011048v1 224/3/695    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ho, V. B. Articles by Choyke, P. L. Search for Related Content PubMed Articles by Ho, V. B. Articles by Choyke, P. L.

Renal Masses: Quantitative Assessment of Enhancement with Dynamic MR Imaging¹

¹ From the MR Research Division, Department of Radiology and Radiological Sciences, Uniformed Services University of the Health Sciences, 4301 Jones Bridge Rd, Bethesda, MD 20814-4799 (V.B.H., M.N.H., P.L.C.); and Department of Diagnostic Radiology, Warren G. Magnuson Clinical Center, National Institutes of Health, Bethesda, Md (V.B.H., S.F.A., M.N.H., P.L.C.). Received June 14, 2001; revision requested July 6; final revision received February 14, 2002; accepted March 12. Address correspondence to V.B.H. (e-mail: vho@usuhs.mil or vho@nih.gov).

PURPOSE: To establish a quantitative magnetic resonance (MR) imaging contrast enhancement criterion for distinguishing cysts from solid renal lesions.

MATERIALS AND METHODS: Regions of interest were measured in 74 patients with renal lesions evaluated by means of dynamic contrast material–enhanced MR imaging with serial breath-hold spoiled gradient-echo acquisitions. Sensitivity for renal tumors and specificity for renal cysts were established by using percentage of enhancement thresholds that varied between 5% and 35%.

RESULTS: The mean percentage of enhancement at MR imaging for the 50 renal cysts was less than 5%; for the 50 renal tumors, it was 97% or higher. With use of a threshold percentage of enhancement of 15% and results obtained between 2 and 4 minutes after administration of contrast material, all malignancies (sensitivity for tumor, 100%) were diagnosed, and there were 6% or fewer false-positive tumor diagnoses. Lower thresholds resulted in unacceptably high false-positive rates (ie, cysts that appeared to enhance—pseudoenhancement), whereas higher threshold values (>20%) resulted in an unacceptably lower sensitivity for tumors.

CONCLUSION: The optimal percentage of enhancement threshold for distinguishing cysts from malignancies with the imaging technique prescribed was 15%, and the optimal timing for measurement was 2–4 minutes after administration of contrast material.

© RSNA, 2002

Index terms: Kidney, cysts, 81.311 • Kidney, MR, 81.121411, 81.121412, 81.121415, 81.121416, 81.12143 • Kidney neoplasms, 81.311, 81.32 • Magnetic resonance (MR), contrast enhancement, 81.12143

This article has been cited by other articles:

				J. Zhang, Y. Mazaheri Tehrani, L. Wang, N. M. Ishill, L. H. Schwartz, and H. Hricak Renal Masses: Characterization with Diffusion-weighted MR Imaging--A Preliminary Experience Radiology, May 1, 2008; 247(2): 458 - 464. [Abstract] [Full Text] [PDF]

				R. P. Lokken, D. A. Gervais, R. S. Arellano, K. Tuncali, P. R. Morrison, S. Tatli, P. R. Mueller, and S. G. Silverman Inflammatory Nodules Mimic Applicator Track Seeding After Percutaneous Ablation of Renal Tumors Am. J. Roentgenol., October 1, 2007; 189(4): 845 - 848. [Abstract] [Full Text] [PDF]

				S. G. Silverman, K. J. Mortele, K. Tuncali, M. Jinzaki, and E. S. Cibas Hyperattenuating Renal Masses: Etiologies, Pathogenesis, and Imaging Evaluation RadioGraphics, July 1, 2007; 27(4): 1131 - 1143. [Abstract] [Full Text] [PDF]

				G. M. Israel and M. A. Bosniak How I Do It: Evaluating Renal Masses Radiology, August 1, 2005; 236(2): 441 - 450. [Abstract] [Full Text] [PDF]

				D. S. Hartman, P. L. Choyke, and M. S. Hartman From the RSNA Refresher Courses: A Practical Approach to the Cystic Renal Mass RadioGraphics, October 1, 2004; 24(suppl_1): S101 - S115. [Abstract] [Full Text] [PDF]

				K. Tuncali, E. vanSonnenberg, S. Shankar, K. J. Mortele, E. S. Cibas, and S. G. Silverman Evaluation of Patients Referred for Percutaneous Ablation of Renal Tumors: Importance of a Preprocedural Diagnosis Am. J. Roentgenol., September 1, 2004; 183(3): 575 - 582. [Abstract] [Full Text] [PDF]

				E. M. Hecht, G. M. Israel, G. A. Krinsky, W. Y. Hahn, D. C. Kim, I. Belitskaya-Levy, and V. S. Lee Renal Masses: Quantitative Analysis of Enhancement with Signal Intensity Measurements versus Qualitative Analysis of Enhancement with Image Subtraction for Diagnosing Malignancy at MR Imaging Radiology, August 1, 2004; 232(2): 373 - 378. [Abstract] [Full Text] [PDF]

				G. M. Israel and M. A. Bosniak Follow-Up CT of Moderately Complex Cystic Lesions of the Kidney (Bosniak Category IIF) Am. J. Roentgenol., September 1, 2003; 181(3): 627 - 633. [Abstract] [Full Text] [PDF]